Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

811 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy.
Jarskog LF, Lowy MT, Grove RA, Keefe RS, Horrigan JP, Ball MP, Breier A, Buchanan RW, Carter CS, Csernansky JG, Goff DC, Green MF, Kantrowitz JT, Keshavan MS, Laurelle M, Lieberman JA, Marder SR, Maruff P, McMahon RP, Seidman LJ, Peykamian MA. Jarskog LF, et al. Among authors: lieberman ja. Schizophr Res. 2015 May;164(1-3):136-42. doi: 10.1016/j.schres.2015.01.041. Epub 2015 Feb 24. Schizophr Res. 2015. PMID: 25728831 Clinical Trial.
Ziprasidone alternative for olanzapine-induced hyperglycemia.
Spivak B, Alamy SS, Jarskog LF, Sheitman BB, Lieberman JA. Spivak B, et al. Among authors: lieberman ja. Am J Psychiatry. 2002 Sep;159(9):1606. doi: 10.1176/appi.ajp.159.9.1606. Am J Psychiatry. 2002. PMID: 12202289 No abstract available.
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development.
Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick ID, Canive JM, McGee MF, Simpson GM, Stevens MC, Lieberman JA. Stroup TS, et al. Among authors: lieberman ja. Schizophr Bull. 2003;29(1):15-31. doi: 10.1093/oxfordjournals.schbul.a006986. Schizophr Bull. 2003. PMID: 12908658 Clinical Trial.
Secretin for refractory schizophrenia.
Sheitman BB, Knable MB, Jarskog LF, Chakos M, Boyce LH, Early J, Lieberman JA. Sheitman BB, et al. Among authors: lieberman ja. Schizophr Res. 2004 Feb 1;66(2-3):177-81. doi: 10.1016/S0920-9964(03)00068-9. Schizophr Res. 2004. PMID: 15061251 Clinical Trial.
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
Keefe RS, Seidman LJ, Christensen BK, Hamer RM, Sharma T, Sitskoorn MM, Lewine RR, Yurgelun-Todd DA, Gur RC, Tohen M, Tollefson GD, Sanger TM, Lieberman JA. Keefe RS, et al. Among authors: lieberman ja. Am J Psychiatry. 2004 Jun;161(6):985-95. doi: 10.1176/appi.ajp.161.6.985. Am J Psychiatry. 2004. PMID: 15169686 Clinical Trial.
Physical health monitoring of patients with schizophrenia.
Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT Jr, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S. Marder SR, et al. Among authors: lieberman ja. Am J Psychiatry. 2004 Aug;161(8):1334-49. doi: 10.1176/appi.ajp.161.8.1334. Am J Psychiatry. 2004. PMID: 15285957 Review.
811 results